Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
Fields of Study & Subjects
Inflammatory Bowel Disease
Biosimilars and Bioanalytical Methods
Rheumatoid Arthritis Research and Therapies
Publication details
- Journal / source
- The Lancet. Gastroenterology & hepatology
- Publisher
- Elsevier BV
- Volume
- 11
- Issue
- 9
- Pages
- 786–796
- Publication date
- 16 July 2026
- Language
- EN